Rice Bran Oil Compared to Atorvastatin for Treatment of Dyslipidemia in Patients with Type 2 Diabetes
DOI:
https://doi.org/10.3889/oamjms.2014.017Keywords:
Rice bran oil, atorvastatin, type 2 diabetes, glycosylated hemoglobin, serum lipids.Abstract
Objective: To compare the effect of rice bran oil versus statins (atorvastatin drug) on blood glucose, glycosylated hemoglobin (HbA1C) and serum lipid profiles in patients with type 2 diabetes. The safety of the tested rice bran oil and atorvastatin were investigated. Fatty acids contents of RBO, olive and sesame oil were also assessed.
Materials and Methods: Forty four eligible patients with type 2 diabetes and moderately hyperlipidemic were randomly and equally allocated into two groups, rice bran oil (RBO) group and atorvastatin group. The RBO group received a low-calorie diet and consumed 30Â g / day RBO oil as salad dressing and for use as main cooking oil for 6 months. The Atorvastatin group received a low-calorie diet and 40 mg/day of atorvastatin drug for 6 months. At baseline and after 6 months of study intervention, blood glucose, glycosylated hemoglobin (HbA1c), serum lipid profiles; hepatic, renal and inflammatory biomarkers were estimated.
Results: Results showed significant increase in fasting and postprandial blood glucose, HbA1C and liver transaminases (alanine transaminase ALT and aspartate transaminase AST) in the atorvastatin group while a significant reduction was shown in RBO group. Moreover, significant reductions in lipid profile levels, blood urea, serum uric acid and erythrocyte sedimentation rate (ESR) were observed in both RBO and atorvastatin groups after 6 months of the study intervention.
Conclusion: The use of rice bran oil together with dietary modifications may have implications in lowering fasting and postprandial blood glucose, suppressing serum lipid levels, reduce the TC/HDL-C ratio and therefore reducing the risk of cardiovascular disease. Moreover, RBO exerts a hypouricemic action and anti-inflammatory effects. The findings obtained from the current study reinforce the use of RBO as an alternative natural potent hypolipidemic agent safer than atorvastatin drug that may induce side effects in some cases in patients intolerant to statins.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Kota SK, Jammula S, Kota SK, et al. Nutraceuticals in dyslipidemia management. J Med Nutr Nutraceut.2013; 2(1): 26-40. DOI: https://doi.org/10.4103/2278-019X.105328
WHO. World health statistics 2009. Geneva: World Health Organization; 2009e.
Shah RV, Goldfine AB. Statins and Risk of New-Onset Diabetes Mellitus. Circulation. 2012; 126: e282-e284.
Björnsson E, Jacobsen EI, Kalaitzakis E. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. J Hepatol. 2012; 56(2): 374-80.
Halbert SC, French B, Gordon RY, Farrar JT, Schmitz K, Morris PB, Thompson PD, Rader DJ, Becker DJ. Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance. Am J Cardiol. 2010; 105(2): 198-204.
Maji D, Shaikh S, Solanki D, Gaurav K. Safety of statins. Indian J Endocrinol Metab. 2013; 17(4): 636-46. DOI: https://doi.org/10.4103/2230-8210.113754
Dubois V, Breton S, Linder M, Fanni, J, Parmentier M. Fatty acid profiles of 80 vegetable oils with regard to their nutritional potential. Eur J Lipid Sci Technol. 2007; 109: 710–32. DOI: https://doi.org/10.1002/ejlt.200700040
Friedman M. Rice brans, rice bran oils, and rice hulls: composition, food and industrial uses, and bioactivities in humans, animals, and cells. J Agric Food Chem. 2013;61(45):10626-41. DOI: https://doi.org/10.1021/jf403635v
Elmont J. A study of the possibilities to add value to and improve the utilization of rice bran in suriname – (ACP Project: 09 ACPSUR 007), May-June 2010.
Machchhar DS, Ghatak SB, Kansara UA, et al. Antihyperlipidemic activity of various combinations of rice bran oil and safflower oil on Triton WR– 1339 induced hyperlipidemia in rats. JPB Science. 2012; 1(1): 16-26.
Abumweis SS, Barake R, Jones PJ. Plant sterols/stanols as cholesterol lowering agents: A meta-analysis of randomized controlled trial. Food Nutr Res.2008; 52: 1-35. DOI: https://doi.org/10.3402/fnr.v52i0.1811
Orthoefer FT. Rice Bran Oil. Bailey's Industrial Oil and Fat Products. Published Online, 2005. DOI: https://doi.org/10.1002/047167849X.bio015
Niederau CM, Reinauer H. Comparison of analytical methods for the estimation of glycosylated hemoglobins. J Clin Chem Clin Biochem. 1981; 19(11):1097-101.
Trinder, P. Enzymatic method for glucose determination. Ann Clin Biochem. 1969; 6: 24-28. DOI: https://doi.org/10.1177/000456326900600108
Allain CC, Poon LS, Chon CS, Richmond W, Fu P.C. Enzymatic determination of total serum cholesterol. Clin. Chem. 1974; 20: 470-75. DOI: https://doi.org/10.1093/clinchem/20.4.470
Lopes-Virella MF, Stone P, Ellis S, Coldwell JA. Cholesterol determinations in high density liproproteins separated by three methods. Clin Chem. 1977; 23: 882–84. DOI: https://doi.org/10.1093/clinchem/23.5.882
Bucolo G, David H. Quantitative Determination of Serum Triglycerides by the Use of Enzymes. Clin Chem. 1973; 19(5): 476-82. DOI: https://doi.org/10.1093/clinchem/19.5.476
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499–502. DOI: https://doi.org/10.1093/clinchem/18.6.499
Reitman S, Frankel S. A colorimetric method for determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Am J Clin. Pathol. 1957; 28; 56-63. DOI: https://doi.org/10.1093/ajcp/28.1.56
Fabinay DL, Eringhausen G. Quantitative kinetic determination of creatinine in serum. Clin Chem. 1971; 17: 696-700. DOI: https://doi.org/10.1093/clinchem/17.8.696
Patton CJ, Grouch SR. Enzymatic colorimetric method for determination of metabolism of urea. Anal Chem. 1977; 49: 464-69. DOI: https://doi.org/10.1021/ac50011a034
Rebar L, Berta E, Stong L. New enzymatic method for serum uric acid at 500 nm. Clin Chem. 1978; 24: 1908–11. DOI: https://doi.org/10.1093/clinchem/24.11.1908
Bull BS, Caswell M, Ernst E, et al. ICSH recommendations for measurement of erythrocyte sedimentation rate. J Clin Pathol. 1993; 46: 198–203. DOI: https://doi.org/10.1136/jcp.46.3.198
Sheppard AJ, Iverson JL. Esterification of fatty acids for gas-liquid chromatographic analysis. J Chromatogr Sci. 1975; 13: 448-52. DOI: https://doi.org/10.1093/chromsci/13.9.448
Baliarsingh S, Beg ZH, Ahmad J. The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia. Atherosclerosis. 2005; 182(2): 367-74. DOI: https://doi.org/10.1016/j.atherosclerosis.2005.02.020
Siddiqui S, Khan MR, Siddiqui WA. Comparative hypoglycemia and nephroprotective effects of tocotrienol rich fraction (TRF) from palm oil and rice bran oil against hyperglycemia induced nephropathy in type 1 diabetic rats. Chem Biol Interact. 2010; 188(3): 651-58. DOI: https://doi.org/10.1016/j.cbi.2010.08.010
Zavoshy R, Noroozi M, Jahanihashemi H. Effect of low calorie diet with rice bran oil on cardiovascular risk factors in hyperlipidemic patients. J Res Med Sci. 2012; 17(7): 626–31.
Muid S, Ali AM, Yusoff K, Nawawi H. Optimal antioxidant activity with moderate concentrations of Tocotrienol rich fraction (TRF) in in vitro assays. Int Food Res J. 2013; 20(2): 687-94.
Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004; 364: 685-96. DOI: https://doi.org/10.1016/S0140-6736(04)16895-5
Yamakawa T, Takano T, Tanaka S, Kadonosono K, Terau-chi Y. Influence of pitavastatin on glucose tolerance in patients with type 2 diabetes mellitus. J Atheroscler Thromb. 2008; 15: 269-75. DOI: https://doi.org/10.5551/jat.E562
Koh KK, Quon MJ, Han SH, Lee Y, Kim SJ, Shin EK. Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients. J Am Coll Cardiol. 2010; 55(12): 1209-16. DOI: https://doi.org/10.1016/j.jacc.2009.10.053
Ray K. Statin diabetogenicity: guidance for clinicians. Cardiovascular Diabetology. 2013; 12 (Suppl 1):S3. DOI: https://doi.org/10.1186/1475-2840-12-S1-S3
Abdin AA, Hassanien MA, Ibrahim EA, Abou El-Noeman SA. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy. J Diabetes Complications. 2010; 24(5): 325-33. DOI: https://doi.org/10.1016/j.jdiacomp.2009.04.001
Simsek S, Schalkwijk CG, Wolffenbuttel BH. Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes---the CORALL study. Diabet Med. 2012; 29(5): 628-31. DOI: https://doi.org/10.1111/j.1464-5491.2011.03553.x
Shah RV, Goldfine AB. Statins and Risk of New-Onset Diabetes Mellitus. Circulation. 2012; 126: e282-e284. DOI: https://doi.org/10.1161/CIRCULATIONAHA.112.122135
Amarasinghe BMWPK, Gangodavilage NC. Rice bran oil extraction in Sri Lanka: Data for process equipment design, Trans IChem, Part C. Food and Bio products processing. 2004; 82(C1): 54-59. DOI: https://doi.org/10.1205/096030804322985326
Chen CW, Cheng HH. A rice bran oil diet increases LDL-Receptor and HMG-CoA Reductase mRNA expressions and insulin sensitivity in rats with streptozotocin/nicotinamide-induced Type 2 Diabetes. J. Nutr. 2006; 136(6): 1472-76. DOI: https://doi.org/10.1093/jn/136.6.1472
Chou TW, Ma CY, Cheng HH, Chen YY, Lai MH. A rice bran oil diet improves lipid abnormalities and suppress hyperinsulinemic responses in rats with streptozotocin/nicotinamide-induced Type 2 Diabetes. J Clin Biochem Nutr. 2009; 45(1): 29-36. DOI: https://doi.org/10.3164/jcbn.08-257
Wan Nazaimoon WM, Khalid BA. Tocotrienols-rich diet decreases advanced glycosylation end-products in non-diabetic rats and improves glycemic control in streptozotocin-induced diabetic rats. Malays J Pathol. 2002; 24(2): 77-82.
Ghatak SB, Panchal SS. Protective effect of oryzanol isolated from crude rice bran oil in experimental model of diabetic neuropathy. Braz J Pharmacog. 2012; 22(5): 1092-1103. DOI: https://doi.org/10.1590/S0102-695X2012005000104
Shanmugam KR, Ramakrishna CH, Mallikarjuna K, Reddy S. Perturbation in kidney lipid metabolic profiles in diabetic rats with reference to alcoholic oxidative stress. Indian J Nephrol. 2009; 19(3): 101-06. DOI: https://doi.org/10.4103/0971-4065.57106
Lee JW, Lee SW, Kim MK, Rhee C, Kim IH, Lee KW. Beneficial effect of the unsaponifiable matter from rice bran oil on oxidative stress in vitro compared with ά-tocopherol. J Sci Food Agric. 2005;85:493–8. DOI: https://doi.org/10.1002/jsfa.2009
Cicero AFG, Derosa G. Rice bran and its main components: Potential role in the management of coronary risk factors. Curr Top Nutraceu R. 2005; 3(1): 29-46.
Ros E. Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes. Am J Clin Nutr. 2003; 78(3): 617S-25S. DOI: https://doi.org/10.1093/ajcn/78.3.617S
Zhao G, Etherton TD, Martin KR, et al. Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr. 2004; 134(11): 2991-97. DOI: https://doi.org/10.1093/jn/134.11.2991
Lai MH, Chen YT, Chen YY, Chang JH, Cheng HH. Effects of rice bran oil on the blood lipids profiles and insulin resistance in type 2 diabetes patients. J Clin Biochem Nutr. 2012; 51(1): 15-18. DOI: https://doi.org/10.3164/jcbn.11-87
Oluremi OI , SolomonAO, Saheed AA. Fatty acids, metal composition and physico-chemical parameters of Igbemo Ekiti rice bran oil. J Environ Chem Ecotoxicol. 2013; 5(3): 39-46. J. Environ. Sci. Health
Edwards MS, Radcliffe JD. A comparison of the effect of rice bran oil and corn oil on lipid status in the rat. Biochem Arch. 1994; 10: 87-94.
Hota D, Chakrabarti A, Dutta P, Singh I. A Comparative Evaluation of Anti-hyperlipidemic efficacy of Rice bran oil, Olive oil and Groundnut oil. Clinical study report. Postgraduate Institute of Medical education and Research, Chandigarh-160012. www.ricela.com/images/Final-Report.pdf. 2013; 1-84.
Tabassum S, Aggarwal S, Ali SM, et al. Effect of rice bran oil on the lipid profile of steroid responsive nephrotic syndrome. Indian J Nephrol. 2005; 15: 10-13.
Mäkynen K, Chitchumroonchokchai C, Adisakwattana S, Failla M, Ariyapitipun T. Effect of gamma-oryzanol on the bioaccessibility and synthesis of cholesterol. Eur Rev Med Pharmacol Sci. 2012; 16(1): 49-56.
Houston MC, Fazio S, Chilton FH, et al. Nonpharmacologic Treatment of Dyslipidemia. Prog Cardiovasc Dis. 2009; 52: 61-94. DOI: https://doi.org/10.1016/j.pcad.2009.02.002
Vasanthi HR, Parameswari RP, Das DK. Multifaceted role of tocotrienols in cardioprotection supports their structure: function relation. Genes Nutr. 2012; 7(1): 19-28. DOI: https://doi.org/10.1007/s12263-011-0227-9
: Agarwal S, Ferreira VP, Cortes C, et al. An Evaluation of the Role of Properdin in Alternative Pathway Activation on Neisseria meningitidis and Neisseria gonorrhoeae. J Immunol. 2010; 185(1): 507-16. DOI: https://doi.org/10.4049/jimmunol.0903598
Choudhary M, Grover K. Blended rice bran and olive oil –moving towards a new cooking media. IJLSER. 2013; 1(1): 14-20.
Rukmini C, Raghuram TC. Nutritional and biochemical aspects of the hypolipidemic action of rice bran oil: a review. J Am Coll Nutr. 1991; 10(6): 593-601. DOI: https://doi.org/10.1080/07315724.1991.10718181
Tsutsumi K. Lipoprotein lipase and atherosclerosis. Curr Vasc Pharmacol. 2003; 1(1): 11-17. DOI: https://doi.org/10.2174/1570161033386673
Eady S, Wallace A, Willis J, Scott R, Frampton C. Consumption of a plant sterol-based spread derived from rice bran oil is effective at reducing plasma lipid levels in mildly hypercholesterolaemic individuals. Br J Nutr. 2011;15: 1–12. DOI: https://doi.org/10.1017/S0007114510005519
Zavoshy R, Noroozi M, Jahanihashemi H. Effect of low calorie diet with rice bran oil on cardiovascular risk factors in hyperlipidemic patients. J Res Med Sci. 2012; 17(7): 626–631.
Fowler MJ. Microvascular and Macrovascular Complications of Diabetes. Clin Diabetes. 2008; 26: 277-282. DOI: https://doi.org/10.2337/diaclin.26.2.77
Hajar R. Statins: Past and present. Heart views. 2011; 12(3): 121-27. DOI: https://doi.org/10.4103/1995-705X.95070
Diffenderfer MR, Brousseau ME, Millar JS, et al. Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism. J Lipid Res. 2012; 53(6): 1190-99. DOI: https://doi.org/10.1194/jlr.M019570
Srinivasa Rao K, Prasad T, Mohanta GP, Manna PK. An Overview of Statins as Hypolipidemic Drugs. IJPSDR. 2011; 3(3): 178-83.
Liu Y, Cheng Z, Ding L, et al. Atorvastatin-induced acute elevation of hepatic enzymes and the absence of cross-toxicity of pravastatin. Int J Clin Pharmacol Ther. 2010; 48: 798-802. DOI: https://doi.org/10.5414/CPP48798
Heeba GH, Abd-Elghany MI. Effect of combined administration of ginger (Zingiber officinale Roscoe) and atorvastatin on the liver of rats. Phytomedicine. 2010; 17(14): 1076-81. DOI: https://doi.org/10.1016/j.phymed.2010.04.007
Deshpande PR, Khera K, Thunga G, et al. Atorvastatin-induced acute pancreatitis. J Pharmacol Pharmacother. 2011; 2(1): 40-42. DOI: https://doi.org/10.4103/0976-500X.77114
Björnsson E, Jacobsen EI, Kalaitzakis E. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. J Hepatol. 2012; 56(2): 374-80. DOI: https://doi.org/10.1016/j.jhep.2011.07.023
Halbert SC, French B, Gordon RY, et al. Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance. AMJC. 2010; 105(2): 198-204. DOI: https://doi.org/10.1016/j.amjcard.2009.08.672
Chang CH, Kusama M, Ono S, et al. Assessment of statin-associated muscle toxicity in Japan: a cohort study conducted using claims database and laboratory information. BMJ Open. 2013; 3(4): 1-9. DOI: https://doi.org/10.1136/bmjopen-2012-002040
Barakat L, Jayyousi A, Bener A, Zuby B, Zirie M. Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients. ISRN Pharmacology. 2013; 2013:1-7. DOI: https://doi.org/10.1155/2013/146579
Athyros VG, Mikhailidis DP, Liberopoulos EN. et al. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome. Nephrol Dial Transplant. 2007; 22: 118–127 DOI: https://doi.org/10.1093/ndt/gfl538
Milionis HJ, Kakafika AI, Tsouli SG et al. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am Heart J. 2004; 148:635-40. DOI: https://doi.org/10.1016/j.ahj.2004.04.005
Macin SM, Perna ER, Fanas EF et al. Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome results of a randomized double blind placebo controlled study. Am Heart J. 2005; 149 (3): 451-7. DOI: https://doi.org/10.1016/j.ahj.2004.07.041
Choudhary M, Grover K, Sangha J. Effect of Blended Rice Bran and Olive Oil on Cardiovascular Risk Factors in Hyperlipidemic Patients. Food and Nutr Sci. 2013; 4: 1084-1093. DOI: https://doi.org/10.4236/fns.2013.411141
Jayachandran S, Muralidharan J, Selvaraj P, Visha P, Nanjappan K. Influence of rice Bran oil as defaunating agent on the performance of Mecheri Ram Lambs. The Indian Journal of Small Ruminants. 2010; 16(1): 101-04.
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0
